Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $44.8900 (-0.09%) ($44.8900 - $44.8900) on Wed. Apr. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.58% (three month average) | RSI | 50 | Latest Price | $44.8900(-0.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.6% a day on average for past five trading days. | Weekly Trend | TGTX declines -0.5% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(67%) ARKG(63%) ARKK(58%) IBB(58%) IWO(58%) | Factors Impacting TGTX price | TGTX will decline at least -1.79% in a week (0% probabilities). VIXM(-42%) VXX(-35%) UUP(-17%) UNG(-3%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.79% (StdDev 3.58%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $38.82(-13.52%) | Inflection Point | Yes | Resistance Level | $46.52 | 5 Day Moving Average | $45.02(-0.29%) | 10 Day Moving Average | $46.24(-2.92%) | 20 Day Moving Average | $46.52(-3.5%) | To recent high | -17.1% | To recent low | 7.7% | Market Cap | $5.685b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |